Uniphar plc (LON:UPR – Get Free Report) insider Gerard Rabbette sold 43,355 shares of the business’s stock in a transaction on Wednesday, December 10th. The stock was sold at an average price of GBX 362, for a total transaction of £156,945.10.
Uniphar Price Performance
LON:UPR opened at GBX 310 on Friday. The business’s 50-day moving average is GBX 330.76 and its 200 day moving average is GBX 330.60. Uniphar plc has a 12 month low of GBX 163 and a 12 month high of GBX 368. The company has a market capitalization of £804.68 million, a P/E ratio of 12.65 and a beta of 0.75. The company has a current ratio of 0.90, a quick ratio of 0.60 and a debt-to-equity ratio of 119.48.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada increased their target price on Uniphar from GBX 470 to GBX 480 and gave the company an “outperform” rating in a research report on Tuesday, September 9th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of GBX 427.50.
About Uniphar
Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology
manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.
Further Reading
- Five stocks we like better than Uniphar
- Golden Cross Stocks: Pattern, Examples and Charts
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Upcoming IPO Stock Lockup Period, Explained
- The Best Holiday Present You Can Give Yourself? Costco Stock
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for Uniphar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Uniphar and related companies with MarketBeat.com's FREE daily email newsletter.
